Video

Rose Gerber: Cancer Patients Made Their Voices Heard on Capitol Hill

When the COA Patient Advocacy Network converged on Capitol Hill on April 26, 50 advocates were able to discuss their concerns with a number of issues facing patients with cancer, including 340B and clinic consolidation, explained Rose Gerber, director of patient advocacy for the Community Oncology Alliance (COA).

When the COA Patient Advocacy Network converged on Capitol Hill on April 26, 50 advocates were able to discuss their concerns with a number of issues facing patients with cancer, including 340B and clinic consolidation, explained Rose Gerber, director of patient advocacy for the Community Oncology Alliance (COA).

Transcript

The COA Patient Advocacy Network recently went to Capital Hill. What were you advocating for?

Yesterday was a very important milestone for the COA Patient Advocacy Network. We brought a group of 50 advocates from across the country, representing 11 different states and multiple community practices, and our goal was to enhance COA's presence on the Hill. As many people know COA and we've done a lot of great work bringing physicians to Capitol Hill, we've brought nurses to Capitol Hill, but this time we wanted to actually bring our patients.

So we did address issues such as the concerns regarding cancer clinic consolidation. We did talk about our concerns as patients over the current issues with the 340B program. Everyone knows we think 340B has a lot of good intent, but we also know that it is a concern for cancer patients.

We talked a lot about cost of care and it was just a great opportunity for advocates to understand how their voice matters all the way from their small towns in Georgia to Capitol Hill.

Related Videos
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
 Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Dr Cesar Davila-Chapa
Sandra Cuellar, PharmD
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo